Helius Medical Technologies Inc
HSDT2.780USD
-0.050-1.77%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
112.03MMarket Cap
LossP/E TTM
More Details of Helius Medical Technologies Inc Company
Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.
Helius Medical Technologies Inc Info
Ticker SymbolHSDT
Company nameSolana Co
IPO dateJun 27, 2014
CEOAndreeff (Dane C)
Number of employees21
Security typeOrdinary Share
Fiscal year-endJun 27
Address642 Newtown Yardley Road
CityNEWTOWN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code18940
Phone12159446100
Websitehttps://heliusmedical.com/
Ticker SymbolHSDT
IPO dateJun 27, 2014
CEOAndreeff (Dane C)
Company Executives of Helius Medical Technologies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
15.00
-6.25%
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
2.00
-33.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Mr. Dane C. Andreeff
Mr. Dane C. Andreeff
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Cosmo Jiang
Mr. Cosmo Jiang
Director
Director
--
--
Dr. Joseph Chee
Dr. Joseph Chee
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
15.00
-6.25%
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
2.00
-33.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
Canada
26.00K
60.47%
Other revenue
10.00K
23.26%
United States
7.00K
16.28%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Nov 20
Updated: Thu, Nov 20
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fusion Summer Ltd
16.54%
Pantera Capital Partners LP
9.44%
Solana Rocket Holdings Ltd
9.41%
Polar Asset Management Partners Inc.
5.28%
Aristeia Capital, L.L.C.
2.64%
Other
56.70%
Shareholders
Shareholders
Proportion
Fusion Summer Ltd
16.54%
Pantera Capital Partners LP
9.44%
Solana Rocket Holdings Ltd
9.41%
Polar Asset Management Partners Inc.
5.28%
Aristeia Capital, L.L.C.
2.64%
Other
56.70%
Shareholder Types
Shareholders
Proportion
Corporation
25.96%
Hedge Fund
12.85%
Investment Advisor
9.87%
Investment Advisor/Hedge Fund
1.10%
Research Firm
0.06%
Individual Investor
0.02%
Other
50.14%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
24
3.90M
10.09%
+3.90M
2025Q2
37
12.45K
1.83%
+11.99K
2025Q1
40
16.72K
1.11%
-2.03K
2024Q4
43
261.97K
7.03%
-14.04K
2024Q3
43
183.78K
9.58%
-95.02K
2024Q2
46
285.33K
12.75%
+168.92K
2024Q1
47
120.01K
13.52%
+4.71K
2023Q4
50
81.05K
12.51%
-44.86K
2023Q3
52
56.40K
16.69%
-20.37K
2023Q2
56
42.39K
14.78%
-10.21K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fusion Summer Ltd
6.83M
17.56%
+6.83M
--
Sep 18, 2025
Pantera Capital Partners LP
3.89M
9.99%
+3.89M
--
Sep 18, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jun 27, 2025
Merger
50→1
Apr 30, 2025
Merger
15→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Date
Type
Ratio
Jun 27, 2025
Merger
50→1
Apr 30, 2025
Merger
15→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
FAQs
Who are the top five shareholders of Helius Medical Technologies Inc?
The top five shareholders of Helius Medical Technologies Inc are:
Fusion Summer Ltd holds 6.83M shares, accounting for 17.56% of the total shares.
Pantera Capital Partners LP holds 3.89M shares, accounting for 9.99% of the total shares.
Fusion Summer Ltd holds 6.83M shares, accounting for 17.56% of the total shares.
Pantera Capital Partners LP holds 3.89M shares, accounting for 9.99% of the total shares.
What are the top three shareholder types of Helius Medical Technologies Inc?
The top three shareholder types of Helius Medical Technologies Inc are:
Fusion Summer Ltd
Pantera Capital Partners LP
Solana Rocket Holdings Ltd
Fusion Summer Ltd
Pantera Capital Partners LP
Solana Rocket Holdings Ltd
How many institutions hold shares of Helius Medical Technologies Inc (HSDT)?
As of 2025Q3, 24 institutions hold shares of Helius Medical Technologies Inc, with a combined market value of approximately 3.90M, accounting for 10.09% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 8.26%.
What is the biggest source of revenue for Helius Medical Technologies Inc?
In FY2025Q2, the -- business generated the highest revenue for Helius Medical Technologies Inc, amounting to -- and accounting for --% of total revenue.
